Merck & Co. Inc.
Merck & Co. Inc. logo
MRK

Merck & Co. Inc. (MRK)

$110.121.18%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$107.67
Day's Range
$110.12
$69.08
52-Week Range
$110.33
1 month return10.38%
3 month return26.36%
1 year return47.93%
5 year return97.1%

Company Information

Merck & Co., Inc. is an American multinational pharmaceutical company. The corporation conducts business outside of the United States and Canada under Merck Sharp & Dohme (MSD). It was founded as an American subsidiary of the German pharmaceutical company Merck & Co. in 1891. The company was given this name in honour of the Merck family. Merck acquired the Livogen trademark from Glaxo India for Rs 8 crore in 2000 - well over the market value. According to the company, Rofecoxib will be distributed in the Philippines via a co-marketing arrangement with the local pharmaceutical business Kopran. When Biochem Pharmaceutical Industries Ltd purchased Taloja in 2004, the firm spent a total of Rs 100 million, making it the most costly acquisition the company had made then. On March 27, 2002, a decision was made to rename the company from E Merck (India) Ltd to Merck Ltd, and the company was officially constituted on that day. This increased the firm's capacity for the manufacturing of Bulk Drugs by 33 tonnes in 2006, increasing the company's overall production capacity to 351 tonnes. In 2020, the pharmaceutical business will have six blockbuster medications or products with more than $1 billion in revenue. An antibody used to treat cancer is Keytruda, estimated to make $14.3 billion this year. Varivax is supposed to make $3.9 billion each, and Gardasil will make $1.4 billion each. Currently Merck & Co Inc has a market cap of $275.95 Billion. It has a P.E ratio of 18.08. The shares of Merck & Co Inc are trading at $110.12. .
OrganizationMerck & Co. Inc.
Employees67000
CEOMr. Kenneth C. Frazier
IndustryHealth Technology

Analyst Recommendation

based on 25 analysts ratings

Buy
60%
Buy
40%
Hold
0%
Sell

Based on 25 Wall street analysts offering stock ratings for Merck & Co. Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 0.21%

Current

$110.12

Target

$110.35

Recommendation Trend

Based on 25 analyst

Current1M Ago3M Ago
Buy
15
21
23
Hold
10
10
10
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
276.0B
Book Value
$17.55
Dividend Share
2.72
Dividend Yield
2.5%
Earnings Per Share (EPS)
6.01
PE Ratio
15.98
PEG Ratio
1.31
Wall Street Target Price
110.35

Valuation

Trailing PE18.05
Forward PE14.25
Price/Book (mrq)
6.13
Enterprise Value
291.7B
Enterprise Value/Revenue
4.95
Enterprise Value/Ebitda
13.49

Technicals

Beta
0.39
50 Day MA
95.78
200 Day MA
89.0

Sustainability

Rating Date2019-01-01
Total Esg
28.35
Total Esg Percentile
47.16
Environment Score3.15
Environment Score Percentile4.0
Social Score15.55
Social Score Percentile4.0
Governance Score12.65
GovernanceScorePercentile4.0
Controversy Level3.0

Institutional Holdings

Vanguard Group Inc

8.84%

State Street Corporation

4.63%

Geode Capital Management, LLC

1.81%

Wellington Management Company LLP

1.58%

Bank of America Corp

1.53%

Bank of New York Mellon Corp

1.22%

Discover more

Frequently Asked Questions

What is Merck & Co. Inc. share price today?

Can Indians buy Merck & Co. Inc. shares?

How can I buy Merck & Co. Inc. shares from India?

Can Fractional shares of Merck & Co. Inc. be purchased?

What are the documents required to start investing in Merck & Co. Inc. stocks?

What are today’s High and Low prices of Merck & Co. Inc.?

What are today’s traded volumes of Merck & Co. Inc.?

What is today’s market capitalisation of Merck & Co. Inc.?

What is the 52 Week High and Low Range of Merck & Co. Inc.?

How much percentage Merck & Co. Inc. is down from its 52 Week High?

How much percentage Merck & Co. Inc. is up from its 52 Week low?

What are the historical returns of Merck & Co. Inc.?

Who is the Chief Executive Officer (CEO) of Merck & Co. Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*